Select Publications
Journal articles
2020, 'More-than-harm reduction: Engaging with alternative ontologies of ‘movement’ in UK drug services', International Journal of Drug Policy, 82, http://dx.doi.org/10.1016/j.drugpo.2020.102771
,2020, 'Wastewater monitoring of SARS-CoV-2: lessons from illicit drug policy', The Lancet Gastroenterology and Hepatology, 5, pp. 641 - 642, http://dx.doi.org/10.1016/S2468-1253(20)30158-8
,2020, 'Modelling the pandemic: Attuning models to their contexts', BMJ Global Health, 5, pp. e002914, http://dx.doi.org/10.1136/bmjgh-2020-002914
,2020, '“Towards eliminating viral hepatitis”: Examining the productive capacity and constitutive effects of global policy on hepatitis C elimination', International Journal of Drug Policy, 80, http://dx.doi.org/10.1016/j.drugpo.2019.02.008
,2020, 'A model society: maths, models and expertise in viral outbreaks', Critical Public Health, 30, pp. 253 - 256, http://dx.doi.org/10.1080/09581596.2020.1748310
,2020, 'Mathematical models as public troubles in COVID-19 infection control: following the numbers', Health Sociology Review, 29, pp. 177 - 194, http://dx.doi.org/10.1080/14461242.2020.1764376
,2020, 'Editing the International Journal of Drug Policy', International Journal of Drug Policy, 76, pp. 102664, http://dx.doi.org/10.1016/j.drugpo.2020.102664
,2020, 'Making evidence and policy in public health emergencies: Lessons from COVID-19 for adaptive evidence-making and intervention', Evidence and Policy, 16, pp. 477 - 490, http://dx.doi.org/10.1332/174426420X15913559981103
,2019, 'Evidence-making hepatitis C cure: Towards a science that knows more carefully', International Journal of Drug Policy, 72, pp. 40 - 46, http://dx.doi.org/10.1016/j.drugpo.2019.06.023
,2019, 'Evidence-making interventions in health: A conceptual framing', Social Science and Medicine, 238, http://dx.doi.org/10.1016/j.socscimed.2019.112488
,2019, 'Assessing risk of HIV and hepatitis C among people who inject drugs in East Africa: Findings from a rapid assessment', Journal of Viral Hepatitis, 26, pp. 926 - 929, http://dx.doi.org/10.1111/jvh.13088
,2019, 'Causes of death among persons diagnosed with hepatitis C infection in the pre- and post-DAA era in England: A record linkage study', JOURNAL OF VIRAL HEPATITIS, 26, pp. 873 - 880, http://dx.doi.org/10.1111/jvh.13096
,2019, 'A ‘promising tool’? A critical review of the social and ethico-political effects of wastewater analysis in the context of illicit drug epidemiology and drug policy', Current Opinion in Environmental Science and Health, 9, pp. 85 - 90, http://dx.doi.org/10.1016/j.coesh.2019.06.006
,2019, 'Evidence-making controversies: the case of hepatitis C treatment and the promise of viral elimination', Critical Public Health, 29, pp. 260 - 273, http://dx.doi.org/10.1080/09581596.2018.1459475
,2019, ''Just another vial': A qualitative study to explore the acceptability and feasibility of routine blood-borne virus testing in an emergency department setting in the UK', BMJ Open, 9, http://dx.doi.org/10.1136/bmjopen-2018-024085
,2019, 'Understanding how, why, for whom, and under what circumstances opt-out blood-borne virus testing programmes work to increase test engagement and uptake within prison: A rapid-realist review', BMC Health Services Research, 19, http://dx.doi.org/10.1186/s12913-019-3970-z
,2019, 'Integrated and differentiated methadone and HIV care for people who use drugs: A qualitative study in Kenya with implications for implementation science', Health Policy and Planning, 34, pp. 110 - 119, http://dx.doi.org/10.1093/heapol/czz002
,2019, 'The becoming-methadone-body: on the onto-politics of health intervention translations', Sociology of Health and Illness, 41, http://dx.doi.org/10.1111/1467-9566.12978
,2019, '"A more accurate understanding of drug use": A critical analysis of wastewater analysis technology for drug policy', International Journal of Drug Policy, 63, pp. 47 - 55, http://dx.doi.org/10.1016/j.drugpo.2018.10.011
,2018, 'Caring and curing: Considering the effects of hepatitis C pharmaceuticalisation in relation to non-clinical treatment outcomes', International Journal of Drug Policy, 60, pp. 24 - 32, http://dx.doi.org/10.1016/j.drugpo.2018.07.015
,2018, 'DIY HIV prevention: Formative qualitative research with men who have sex with men who source PrEP outside of clinical trials', PLoS ONE, 13, http://dx.doi.org/10.1371/journal.pone.0202830
,2018, 'Fentanyl self-testing outside supervised injection settings to prevent opioid overdose: Do we know enough to promote it?', International Journal of Drug Policy, 58, pp. 31 - 36, http://dx.doi.org/10.1016/j.drugpo.2018.04.017
,2018, 'Understanding hepatitis C intervention success—Qualitative findings from the HepCATT study', Journal of Viral Hepatitis, 25, pp. 762 - 770, http://dx.doi.org/10.1111/jvh.12869
,2018, 'A qualitative assessment of the acceptability of hepatitis C remote self-testing and self-sampling amongst people who use drugs in London, UK', BMC Infectious Diseases, 18, http://dx.doi.org/10.1186/s12879-018-3185-7
,2018, '“It’s Not Much of a Life”: The Benefits and Ethics of Using Life History Methods With People Who Inject Drugs in Qualitative Harm Reduction Research', Qualitative Health Research, 28, pp. 1123 - 1134, http://dx.doi.org/10.1177/1049732318764393
,2018, 'The becoming of methadone in Kenya: How an intervention's implementation constitutes recovery potential', Social Science and Medicine, 201, pp. 71 - 79, http://dx.doi.org/10.1016/j.socscimed.2018.02.007
,2018, '"They accept me, because I was one of them": Formative qualitative research supporting the feasibility of peer-led outreach for people who use drugs in Dakar, Senegal', Harm Reduction Journal, 15, http://dx.doi.org/10.1186/s12954-018-0214-1
,2018, 'The social life of HIV care: On the making of ‘care beyond the virus’', BioSocieties, http://dx.doi.org/10.1057/s41292-018-0129-9
,2017, 'Risk Environments and the Ethics of Reducing Drug-Related Harms', American Journal of Bioethics, 17, pp. 46 - 48, http://dx.doi.org/10.1080/15265161.2017.1388870
,2017, 'Integrated opioid substitution therapy and HIV care: a qualitative systematic review and synthesis of client and provider experiences', AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 29, pp. 1119 - 1128, http://dx.doi.org/10.1080/09540121.2017.1300634
,2017, 'Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy', International Journal of Drug Policy, 47, pp. 26 - 33, http://dx.doi.org/10.1016/j.drugpo.2017.08.001
,2017, '“Not Taking it Will Just be Like a Sin”: Young People Living with HIV and the Stigmatization of Less-Than-Perfect Adherence to Antiretroviral Therapy', Medical Anthropology: Cross Cultural Studies in Health and Illness, 36, pp. 485 - 499, http://dx.doi.org/10.1080/01459740.2017.1306856
,2017, 'Impact of opioid substitution therapy on the HIV prevention benefit of antiretroviral therapy for people who inject drugs', AIDS, 31, pp. 1181 - 1190, http://dx.doi.org/10.1097/QAD.0000000000001458
,2017, 'The intimate relationship as a site of social protection: Partnerships between people who inject drugs', Social Science and Medicine, 180, pp. 125 - 134, http://dx.doi.org/10.1016/j.socscimed.2017.03.012
,2017, '“Don't think I'm going to leave you over it”: Accounts of changing hepatitis C status among couples who inject drugs', Drug and Alcohol Dependence, 173, pp. 78 - 84, http://dx.doi.org/10.1016/j.drugalcdep.2016.12.020
,2017, 'Qualitative study of the BREATHER trial (Short Cycle antiretroviral therapy): Is it acceptable to young people living with HIV?', BMJ Open, 7, http://dx.doi.org/10.1136/bmjopen-2016-012934
,2017, 'Transitions at the International Journal of Drug Policy', International Journal of Drug Policy, 39, pp. 141 - 142, http://dx.doi.org/10.1016/j.drugpo.2016.12.002
,2016, 'Access to HIV treatment and care for people who inject drugs in Kenya: a short report', AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 28, pp. 1595 - 1599, http://dx.doi.org/10.1080/09540121.2016.1191606
,2016, 'The biopolitics of engagement and the HIV cascade of care: a synthesis of the literature on patient citizenship and antiretroviral therapy', Critical Public Health, 26, pp. 501 - 517, http://dx.doi.org/10.1080/09581596.2016.1140127
,2016, 'Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis', Clinical Infectious Diseases, 63, pp. 1094 - 1104, http://dx.doi.org/10.1093/cid/ciw416
,2016, ''They won't change it back in their heads that we're trash': the intersection of sex work-related stigma and evolving policing strategies', Sociology of health & illness, 38, pp. 1137 - 1150, http://dx.doi.org/10.1111/1467-9566.12436
,2016, 'HIV self-testing among men who have sex with men (MSM) in the UK: A qualitative study of barriers and facilitators, intervention preferences and perceived impacts', PLoS ONE, 11, http://dx.doi.org/10.1371/journal.pone.0162713
,2016, 'Practices of partnership: Negotiated safety among couples who inject drugs', Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine, http://dx.doi.org/10.1177/1363459316660859
,2016, 'BREATHER (PENTA 16) short-cycle therapy (SCT) (5 days on/2 days off) in young people with chronic human immunodeficiency virus infection: An open, randomised, parallel-group phase II/III trial', Health Technology Assessment, 20, pp. 1 - 107, http://dx.doi.org/10.3310/hta20490
,2016, 'Advancing the science, methods and practices of drug policy research', International Journal of Drug Policy, 31, pp. 1 - 3, http://dx.doi.org/10.1016/j.drugpo.2016.04.010
,2016, 'An ethnographic exploration of drug markets in Kisumu, Kenya', International Journal of Drug Policy, 30, pp. 82 - 90, http://dx.doi.org/10.1016/j.drugpo.2016.01.001
,2016, 'Drug harms and drug policies in Sub-Saharan Africa: Implementation science and HIV epidemics', International Journal of Drug Policy, 30, pp. 1 - 6, http://dx.doi.org/10.1016/j.drugpo.2016.02.025
,2016, 'Towards "evidence-making intervention" approaches in the social science of implementation science: The making of methadone in East Africa', International Journal of Drug Policy, 30, pp. 17 - 26, http://dx.doi.org/10.1016/j.drugpo.2016.01.002
,2016, 'Prisons as a source of tuberculosis in Russia', International Journal of Prisoner Health, 12, pp. 45 - 56, http://dx.doi.org/10.1108/IJPH-07-2014-0022
,2015, 'Strategies for achieving universal access to hepatitis C virus prevention and care for people who inject drugs', International Journal of Drug Policy, 26, pp. 1039 - 1040, http://dx.doi.org/10.1016/j.drugpo.2015.07.008
,